Biotech Holdings LtdShs Aktie
WKN DE: 925970 / ISIN: CA0909381018
|
04.09.2025 16:15:00
|
Why This Biotech Company Could Be a Growth Stock Powerhouse
There is no sugarcoating it: Vertex Pharmaceuticals (NASDAQ: VRTX) has faced significant issues this year that have sunk its stock price. The company's shares are down 2% year-to-date, while the S&P 500 is up 9%. But none of that means the biotech company is no longer attractive.In fact, Vertex's challenges this year might have created a solid entry point for a company that can be an excellent growth stock in the next five years and perhaps beyond. Here's why investors shouldn't give up on this biotech stock just yet.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!